Clinical Trials Directory

Trials / Sponsors / Bellerophon

Bellerophon

Industry · 6 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulm
Pulmonary Hypertension, Pulmonary Fibrosis, Sarcoidosis, Pulmonary
Phase 22019-01-30
UnknownA Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonar
Pulmonary Fibrosis, Pulmonary Hypertension
Phase 22017-12-29
TerminatedEffect iNO on Functional Respiratory Imaging in Subjects With WHO Group 3 Pulmonary Hypertension With COPD on
COPD, Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease
EARLY_Phase 12016-10-01
Completed3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension As
Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis
Phase 12015-05-01
AvailableExpanded Access for Patients With Pulmonary Hypertension Associated With Pulmonary Fibrosis
Pulmonary Fibrosis, Pulmonary Hypertension
——
No Longer AvailablePulsed Inhaled Nitric Oxide for the Treatment of Patients With Mild or Moderate COVID-19
Coronavirus Infection, COVID-19, Pneumonia, Viral
——